Literature DB >> 35911876

Single-Session Intranodal Glue Embolization for Postsurgical Refractory Groin Lymphorrhea: A Case Report.

Sho Sosogi1,2, Daisuke Abo1, Ryo Morita1,3, Takeshi Soyama1, Bunya Takahashi1, Yuki Yoshino1, Koji Yamasaki1, Noriyuki Miyamoto2, Kohsuke Kudo3,4.   

Abstract

A 90-year-old female presented with poor right groin wound healing due to lymphorrhea and infection following a surgical cutdown procedure for arterial revascularization. Although negative pressure wound therapy (NPWT) and inguinal lymphadenectomy were performed, infection and lymphorrhea did not heal. Lymphangiography via a right inguinal lymph node revealed lymphatic leakage in the wound. Intranodal glue embolization (IGE) was performed by injecting 0.6 mL of 33% n-butyl-2 cyanoacrylate (NBCA)-lipiodol mixture. Additionally, the presence of glue in an open wound was directly confirmed in this case. After embolization, lymphorrhea ceased, and the wound healed completely. No lymphorrhea recurrence or complications were observed for 6 months. This case suggests that IGE could be an effective treatment for groin lymphorrhea.
© 2022 Japanese Society of Interventional Radiology.

Entities:  

Keywords:  embolization; groin lymphorrhea; intranodal glue embolization; lymphangiography

Year:  2022        PMID: 35911876      PMCID: PMC9327300          DOI: 10.22575/interventionalradiology.2021-0021

Source DB:  PubMed          Journal:  Interv Radiol (Higashimatsuyama)        ISSN: 2432-0935


Introduction

Inguinal lymphorrhea after arterial revascularization is a rare complication. Its onset rate is reported to be between 2% and 15% [1-3]. Prolonged hospitalization and delayed wound infection can occur when a lymphatic fistula persists in the groin area [3]. It has been reported that 70% of patients can be cured from groin lymphorrhea with conservative treatment, such as bed rest with elevation of the leg to reduce lymph flow, intravenous antibiotics, and local wound care [2]. If healing is not achieved conservatively, surgical management or negative pressure wound therapy (NPWT) is generally performed [3]. Several studies have reported that lymphangiography, using iodized oil (Lipiodol; Guerbet, Aulnay-Sous-Bois, France), could not only help diagnose but also treat lymphorrhea [4, 5]. Furthermore, recently, a successful treatment has been described by injecting a mixture of n-butyl-2 cyanoacrylate (NBCA; Histoacryl Blue; B. Braun, Melsungen, Germany) and lipiodol (glue) via an inguinal lymph node for inguinal lymphorrhea (intranodal glue embolization [IGE]) [6]. Even cases of intractable lymphorrhea can be wholly cured with single-session IGE, as in this case.

Case Report

A 90-year-old female underwent percutaneous transfemoral transcatheter aortic valve implantation (TAVI) due to severe aortic valve stenosis. The right external iliac artery accidentally was obstructed during TAVI. Therefore, revascularization under a cutdown procedure of the right groin was promptly performed. The patient had a history of Sjogren's syndrome and rheumatoid arthritis and had been administered medications including 100 mg/day bucillamine and 5 mg/day prednisolone. Pain and lymphorrhea from the inguinal wound appeared after surgery. Based on the patient's clinical course after the cutdown procedure and serous fluid drainage, a diagnosis of lymphatic fistula was established. No laboratory analysis of drainage fluid was performed in this case. Moreover, lymphocele formation and cellulitis were detected by computed tomography (not shown) on the 14th day after TAVI in the right inguinal area. Therefore, for treating lymphocele, an inguinal lymph node resection surgery with ablation was performed on the 23rd day after TAVI. However, the volume of lymphorrhea increased up to about 100-200 mL/day after reoperation. In addition, gram-negative bacilli were detected in the exudate culture, leading to a diagnosis of lymphorrhea with infection. A 2nd reoperation for wound debridement, including lymphadenectomy of the lymph node identified as the cause of lymphorrhea, was performed on the 33rd day after TAVI, and NPWT was initiated for the open wound. Since infection and lymphorrhea persisted (Fig. 1), the cardiovascular surgeons asked for lymphangiography. The patient provided informed consent for the lymphangiography and embolization procedures. An institutional review board approval was obtained for the use of NBCA.
Figure 1.

a: Diagram of the right groin lymphorrhea (yellow pool) in the open wound (red circle). b: Open wound.

a: Diagram of the right groin lymphorrhea (yellow pool) in the open wound (red circle). b: Open wound. On the 38th day after TAVI, ultrasound-guided intranodal lymphangiography with lipiodol was performed using 10 MHz linear probe, 25 G 60-mm needle, and extension tube (50 cm length, 1.0 mm inner diameter, 0.4 mL lumen) (Fig. 2). This procedure was performed via a right inguinal lymph node, which was located slightly caudal from the open wound. It demonstrated leakage of lipiodol in the open wound (Fig. 3). Thus, the decision was made to perform IGE. Lipiodol was washed out by injecting a liquid containing 5% glucose and 1% lidocaine for pain relief purposes in the ratio of 9:1. Thereafter, 0.6 mL of 33% NBCA-lipiodol mixture (glue) was slowly administered under fluoroscopy until glue sufficiently filled the efferent lymphatic vessels up to the leakage point (Fig. 3). After IGE, the presence of glue in the open groin wound was demonstrated visually (Fig. 4). The total procedure time was half an hour.
Figure 2.

Ultrasound (10 MHz linear probe) images. a: Right inguinal lymph node caudal to the open wound. b: Puncturing of the lymph node using 25 G 60-mm needle (white arrow).

Figure 3.

Fluoroscopic images of lymphangiography and intranodal glue embolization. a: Puncturing of the right inguinal lymph node caudal to the open wound using 25 G 60-mm needle (white arrow); lipiodol was then injected (black arrow). b: Accumulation of lipiodol in lymphorrhea from lymphatic duct (white arrow head). c: Lymphangiography demonstrated lipiodol leakage (black arrow head) in the open wound. d: Intranodal glue embolization resulted in the accumulation of NBCA–lipiodol mixture at the site of lymphorrhea in the open wound (black circle).

Figure 4.

Open wound showing bluish-violet discoloration due to NBCA accumulation.

Ultrasound (10 MHz linear probe) images. a: Right inguinal lymph node caudal to the open wound. b: Puncturing of the lymph node using 25 G 60-mm needle (white arrow). Fluoroscopic images of lymphangiography and intranodal glue embolization. a: Puncturing of the right inguinal lymph node caudal to the open wound using 25 G 60-mm needle (white arrow); lipiodol was then injected (black arrow). b: Accumulation of lipiodol in lymphorrhea from lymphatic duct (white arrow head). c: Lymphangiography demonstrated lipiodol leakage (black arrow head) in the open wound. d: Intranodal glue embolization resulted in the accumulation of NBCA–lipiodol mixture at the site of lymphorrhea in the open wound (black circle). Open wound showing bluish-violet discoloration due to NBCA accumulation. Lymphorrhea disappeared completely a day after this IGE. Thereafter, NPWT was continued to cure infection and the wound. The wound healed, and the patient was discharged 95 days post-TAVI. No lymphorrhea recurrence or complications were observed for 6 months after IGE.

Discussion

Surgical ligation of lymphatic vessels is an effective option for lymphorrhea. However, it has potential technical difficulties in identifying damaged lymphatic vessels [7]. In this case, surgical lymphadenectomy and ablation were performed in addition to NPWT. However, they were ineffective. It was suggested that combination treatments failed in this case due to prolonged wound infection and healing after the administration of steroids. In addition, this failure resulted from intractable lymphorrhea due to the weak tissue pressure of the wound caused by the patient's advanced age. Intranodal lymphangiography using lipiodol via an inguinal lymph node plays a role in identifying lymphorrhea in about 90% of cases [8]. Lymphorrhea is sometimes cured by lymphangiography alone due to its ability to cause mild inflammation [8]. However, the treatment effect of lymphangiography is not necessarily promising. Recently, IGE with glue using intranodal lymphangiography has been reported to embolize lymphorrhea [6, 9]. In the present case, single-session IGE could obstruct the intractable lymphorrhea within a shorter treatment period (24 hours after treatment). Chick et al. reported a successful case of IGE for inguinal lymphorrhea, which ceased completely after single-session IGE [9]. On the other hand, another report demonstrated a clinical success rate of 80% for IGE in 10 cases of inguinal lymphorrhea and lymphocele [6]. Only 20% (2 of 10) of these patients were healed 24 hours after IGE. In this report of 10 patients, the median time to resolution was 7 days (range, 1-17) after IGE [6]. In cases that take long time to heal, there may be insufficient accumulation of NBCA in disrupted lymphatic vessels that caused lymphorrhea, and lymphatic flow could be only decreased, not disappear completely. This delayed healing might also be due to the fact that a small amount of lymphorrhea from the collateral lymph vessels could have remained after embolization of the main lymphatic vessels by intralymphatic pressure in the upstream vessels. The inguinal nodes range from 10 to 20 in number and are distributed widely in the groin area [3]. Therefore, it seems that many lymph nodes and efferent lymphatic ducts might have been involved in the formation of groin lymphorrhea. In fact, in 40% of cases, IGE for groin lymphorrhea was required two to four times [6]. In the present case, lymphorrhea healed entirely with a single-session IGE. This might be explained by that most of groin lymphorrhea-related lymph nodes had been already removed by surgical resection before IGE. Furthermore, the glue leaked into the open wound, confirming that it sufficiently filled the efferent lymphatic vessels until the leakage point. As a result, lymphorrhea healed soon after a single-session IGE in this case. Gently injecting a 33%-50% NBCA-lipiodol mixture was important for successful IGE [6, 10], and the dose of glue mixture has been reported to be about 1 mL per session of IGE in cases of groin lymphorrhea and lymphocele [6]. To successfully inject glue to fill the leakage point of the lymphatic duct that was damaged, it seems that the appropriate puncture point might represent the border between the cortex and the medulla of the lymph node. A precise puncturing of the lymph node with ultrasound is essential to ensure that the puncture needle does not deviate from the lymph node due to pressure at the time of glue injection. Generally, precise lymphangiography image interpretation is helpful to confirm the disrupted part of the downstream lymphatic ducts of the punctured lymph node. Also, to fill the embolic material adequately, flushing out the lipiodol stored at the disrupted part before embolization is important. Therefore, we performed embolization with glue after washing out lipiodol using 5% glucose that was X-ray transmissive [10]. In conclusion, as in this case, IGE could be an effective treatment for refractory groin lymphorrhea.

Conflict of Interest

None

Funding

This study was not supported by any funding.

Informed Consent

Written informed consent was obtained from the patient for the publication of this case report and any accompanying images.
  9 in total

Review 1.  Management of lymphatic fistulas after arterial reconstruction in the groin.

Authors:  Christopher P Twine; Ian F Lane; Ian M Williams
Journal:  Ann Vasc Surg       Date:  2013-07-10       Impact factor: 1.466

2.  Intranodal Glue Embolization for the Management of Postsurgical Groin Lymphocele and Lymphorrhea.

Authors:  Amanda R Smolock; Gregory Nadolski; Maxim Itkin
Journal:  J Vasc Interv Radiol       Date:  2018-09-11       Impact factor: 3.464

3.  Lymphography in the Management of Groin Lymphorrhea After Heart Transplantation.

Authors:  Valentin Loobuyck; Natacha Rousse; Ilir Hysi; Francis Juthier; Céline Goeminne; Laurent Lemaitre; André Vincentelli
Journal:  Ann Thorac Surg       Date:  2016-05       Impact factor: 4.330

4.  Early Experience in the Management of Postoperative Lymphatic Leakage Using Lipiodol Lymphangiography and Adjunctive Glue Embolization.

Authors:  Saebeom Hur; Ji Hoon Shin; In Joon Lee; Seung-Kee Min; Sang-Il Min; Sanghyun Ahn; Jinoo Kim; Sang Youn Kim; Minuk Kim; Myungsu Lee; Hyo-Cheol Kim; Hwan Jun Jae; Jin Wook Chung; Hyun Beom Kim
Journal:  J Vasc Interv Radiol       Date:  2016-07-01       Impact factor: 3.464

5.  Single-Session Endolymphatic Glue Embolization of Lymphocele after Heart Transplantation.

Authors:  Jeffrey Forris Beecham Chick; Shilpa N Reddy; Gregory J Nadolski; Yoav Dori; Maxim Itkin
Journal:  J Vasc Interv Radiol       Date:  2016-06-03       Impact factor: 3.464

6.  Direct lymphangiography as treatment option of lymphatic leakage: indications, outcomes and role in patient's management.

Authors:  Tatjana Gruber-Rouh; Nagy N N Naguib; Thomas Lehnert; Marc Harth; Axel Thalhammer; Martin Beeres; Igor Tsaur; Renate Hammersting; Julian L Wichmann; Thomas J Vogl; Volkmar Jacobi
Journal:  Eur J Radiol       Date:  2014-12       Impact factor: 3.528

7.  Groin lymphatic complications after arterial reconstruction.

Authors:  S H Tyndall; A D Shepard; J M Wilczewski; D J Reddy; J P Elliott; C B Ernst
Journal:  J Vasc Surg       Date:  1994-05       Impact factor: 4.268

8.  [A case of refractory inguinal lymphorrhea cured by lipiodol lymphangiography].

Authors:  Koji Tanaka; Shingo Noura; Masayuki Ohue; Yousuke Seki; Kunihito Gotou; Masaaki Motoori; Kentarou Kishi; Kou Takachi; Hidetoshi Eguchi; Terumasa Yamada; Isao Miyashiro; Hiroaki Ohigashi; Masahiko Yano; Osamu Ishikawa; Shingi Imaoka; Kouhei Murata; Masao Kameyama
Journal:  Gan To Kagaku Ryoho       Date:  2007-11

9.  A comparison of conservative therapy and early selective ligation in the treatment of lymphatic complications following vascular procedures.

Authors:  M A Schwartz; H Schanzer; M Skladany; M Haimov; J Stein
Journal:  Am J Surg       Date:  1995-08       Impact factor: 2.565

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.